Immune to Cancer: The CRI Blog
-
How CRI is Taking on Pancreatic Cancer, “The Silent Killer”
Immunotherapy holds the greatest promise for optimizing outcomes for cancer patients, and eventually finding a cure for… -
This is How CRI Funded Scientists are Fighting Breast Cancer
A Global Challenge Breast cancer poses a formidable challenge to healthcare, being one of the most common… -
Honoring Hispanic Immunologists During National Hispanic Heritage Month
Immunotherapy is the most forward-thinking and promising treatment for many types of cancers. Outcomes for childhood cancers,… -
2021 William B. Coley Award Recipients Drs. Katalin Karikó and Drew Weissman Receive the 2023 Nobel Prize in Physiology or Medicine
On October 2 the Nobel Assembly at Karolinska Institute in Stockholm, Sweden, announced that the 2023 Nobel… -
How CRI-Funded Scientists are Reducing and Guarding Against Childhood Cancers
A cancer diagnosis is always extremely difficult news for a patient and their family. It can be… -
Dr. Jill O’Donnell-Tormey on the State of Cancer Immunotherapy and the Contributions CRI Continues to Make to the Field
iFrame is not supported! Recently, the Cancer Research Institute’s (CRI) CEO and Director of Scientific Affairs Jill… -
CRI’s Dr. Jill O’Donnell-Tormey Explains Five Things You Need to Know About Cancer Vaccines
Vaccines had been effective at preventing viral and bacterial-borne viruses for two hundred years before the first… -
Recent Innovations and Challenges in Fighting Blood Cancers
The term “blood cancer” encompasses several types of cancer, including leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes (MDS),… -
Dr. Jill O’Donnell-Tormey Discusses the Latest Developments in Immunological Technologies
CRI’s CEO and Director of Scientific Affairs, Dr. Jill O’Donnell-Tormey, recently spoke with ecancer about recent developments…